Evidence map›Paper›PMID 28414145›Full record

ArticleJournal of pharmaceutical sciences2017

Real-Time Analysis of Tenofovir Release Kinetics Using Quantitative Phosphorus (

Vivek Agrahari, Jianing Meng, Sudhaunshu S Purohit, Nathan A Oyler, Bi-Botti C Youan

Open access · greenAbstract read
In one paragraph

Article in Journal of pharmaceutical sciences, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.7field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Current Strategies and Potential Prospects for Nanoparticle-Mediated Treatment of Diabetic Nephropathy.Diabetes, metabolic syndrome and obesity : targets and therapy · 2022
    Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Vivek AgrahariLaboratory of Future Nanomedicines and Theoretical Chronopharmaceutics, Division of Pharmaceutical Sciences, School of Pharmacy, University of Missouri-Kansas City, Kansas City, Missouri 64108.
Jianing MengLaboratory of Future Nanomedicines and Theoretical Chronopharmaceutics, Division of Pharmaceutical Sciences, School of Pharmacy, University of Missouri-Kansas City, Kansas City, Missouri 64108.
Sudhaunshu S PurohitDepartment of Chemistry, University of Missouri-Kansas City, Kansas City, Missouri 64110.
Nathan A OylerDepartment of Chemistry, University of Missouri-Kansas City, Kansas City, Missouri 64110.
Bi-Botti C YouanLaboratory of Future Nanomedicines and Theoretical Chronopharmaceutics, Division of Pharmaceutical Sciences, School of Pharmacy, University of Missouri-Kansas City, Kansas City, Missouri 64108. Electronic address: youanb@umkc.edu.
University of Missouri–Kansas City · US

Funding

Prevention of HIV/AIDS by Stimuli-Sensitive Nanomedicine for Microbicide DeliveryR01AI087304 · NIAID · UNIVERSITY OF MISSOURI KANSAS CITY · PI YOUAN, BI-BOTTI CELESTIN · 2011 to 2014
$1.4M
NIAID NIH HHS R01 AI087304
6 · The paper itself

Abstract

The dialysis method is classically used for drug separation before analysis, but does not provide direct and real-time drug quantification and has limitations affecting the dialysis rate. In this study, a phosphorus nuclear magnetic resonance (

Indexed as

ChitosanComputer SystemsFemaleHumansKineticsMagnetic Resonance SpectroscopyNanofibersNanoparticlesPhosphorusPlasmaSemenTenofovirVaginaChitosanPhosphorusTenofovircontrolled releaseencapsulationHIV/AIDSHIV vaginal microbicidein vitro/in vivo correlationsnanotechnologyNMR spectroscopyUV/Vis spectroscopy

Identifiers

PMID28414145
PMCPMC5757512
OpenAlexW2606311710

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.